Genomic Biotech - News

BSE: 539206

₹50.50

₹2.40 (4.99%)

As on 02-Nov-2026IST

Market cap

₹15 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

--

P/B Ratio

3.9

Div. Yield

0 %

Annual
Quarterly

Annual Reports

Annual Reports

2025

Annual Reports

2024

Annual Reports

2023

Annual Reports

2022

Annual Reports

2021

Annual Reports

2020

Annual Reports

2019

Annual Reports

2018

Annual Reports

2017

Annual Reports

2016

Annual Reports

2015

Annual Reports

2014

Annual Reports

2013

Annual Reports

2012

Announcements

View Announcements

Recent

Important

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Nov-2026

Un-Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th 2026

30-Oct-2026

Board Meeting Outcome for Pursuant To Regulation 30 Of Sebi (LODR)Regulation 2015 Held On Today I.E. 30Th October 2026

30-Oct-2026

Detailed Public Statement

27-Oct-2026

Disclosure Under Regulation 30 And Regulation 30A Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended ('SEBI (LODR) Regulations')

20-Oct-2026

19-Oct-2026

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

10-Oct-2026

Closure of Trading Window

28-Sep-2026

Intimation Of Approval Of Extension Of Time For Holding Annual General Meeting (AGM) Of The Company For The Financial Year Ended On 31St March 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

31-Aug-2026

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Aug-2026